Related Experiment Video
Updated: Aug 9, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Outpatient treatment trial of mild and severe hypertension
Insights
Treating mild hypertension is feasible and offers advantages. This study found active drug treatment effectively controlled blood pressure in both mild and severe hypertension cases.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Limited data exists on the feasibility and benefits of treating mild hypertension.
- Outpatient management of hypertension presents ongoing challenges.
Purpose of the Study:
- To evaluate the feasibility and effectiveness of treating mild hypertension.
- To assess blood pressure control in mild, moderate, and severe hypertension using specific drugs.
Main Methods:
- A controlled trial involving 56 subjects with mild hypertension (26 active drug, 30 placebo).
- A treatment program for 81 patients with moderate/severe hypertension receiving active drug.
- Follow-up of 12 months or more for 87% (mild) and 80% (severe) hypertension groups.
- Drugs used: bethanidine, debrisoquine, and guanethidine.
Main Results:
- Significant prevalence of cardiac enlargement (45%) and left ventricular hypertrophy (51%) in mild hypertension subjects.
- Rapid blood pressure increases observed in placebo-treated mild hypertension patients.
- Good blood pressure control achieved in 61% (63/104) of patients on active drugs across all severity groups.
- Bethanidine, debrisoquine, and guanethidine demonstrated comparable effectiveness.
Conclusions:
- Treatment of mild hypertension is feasible and indicated, given associated cardiac abnormalities.
- Active drug therapy provides effective blood pressure control in both mild and severe hypertension.
- The studied antihypertensive drugs are similarly effective for blood pressure management.
Abstract:
Not much is known about the feasibility or the advantages of treatment of subjects with only mild hypertension. There are also many unresolved problems in the outpatient management of hypertension of any severity. In this study an analysis is made of the results of a controlled treatment trial of 56 subjects with mild hypertension, 26 of whom were treated with active drug and 30 initially with placebo, and a treatment programme involving 81 patients with moderate or severe hypertension, all of whom received treatment with active drug. The drugs used in this study were bethanidine, debrisoquine, and guanethidine.Follow-up for 12 months or more was achieved in 87% of individuals admitted to the study with mild hypertension and in 80% with severe hypertension. Many subjects with only mildly raised blood pressure were found to have cardiac enlargement on chest x-ray (up to 45%) and left ventricular hypertrophy on electrocardiogram (up to 51%). Rapid rates of rise of blood pressure were observed in many placebo-treated subjects; but good blood pressure control was achieved in 63 out of 104 patients (61%) receiving active drug in both the mild and the severe hypertension groups. The drugs used showed approximately equal effectiveness in controlling blood pressure.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
